Prelude Capital Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Buy
+9,265
New +$212K 0.02% 963
2019
Q4
Sell
-1,100
Closed -$12K 2072
2019
Q3
$12K Buy
+1,100
New +$13.2K ﹤0.01% 1471
2019
Q1
Sell
-1,384
Closed -$24K 1958
2018
Q4
$24K Buy
+1,384
New +$22.5K ﹤0.01% 1221
2017
Q2
Sell
-3,724
Closed -$52K 1714
2017
Q1
$52K Buy
+3,724
New +$43.8K 0.01% 965
2014
Q3
Sell
-8,382
Closed -$250K 1975
2014
Q2
$250K Buy
+8,382
New +$201K 0.03% 655
2013
Q3
Sell
-17,374
Closed -$539K 1774
2013
Q2
$539K Buy
+17,374
New +$466K 0.12% 236

Other funds holding INVA

Prelude Capital Management's INVA Position: Q2 2026 in Review

Prelude Capital Management opened a new position in Innoviva (INVA) in Q2 2026: 9,265 shares worth $210K. The stake represents 0.02% of the portfolio and ranks #963 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in INVA as recently as Q3 2019.

Prelude Capital Management first reported a position in INVA in Q2 2013 and has held it in 6 quarters since. The position peaked at $539K in Q2 2013. 309 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Prelude Capital Management held 9,265 shares of Innoviva worth $210K as of Q2 2026.
  • Innoviva was a new Prelude Capital Management position in Q2 2026.
  • Innoviva made up 0.02% of Prelude Capital Management's portfolio in Q2 2026, its #963 holding.
  • Prelude Capital Management first reported a position in Innoviva in Q2 2013 and has held it in 6 quarters since.
  • Prelude Capital Management's Innoviva position peaked at $539K in Q2 2013.
  • 309 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.